Pemetrexed is an antifolate analog that inhibits enzyme thymidylate synthase (TS) and is also active on dihydrofolate reductase and glycine ribonucleotide folate-dependent enzymes, which forms an effective combination with OXA for locally advanced or metastatic disease treatment (67). The gene discussed is TYMS; the disease is metastatic neoplasm.